Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853202 · ClinicalTrials.gov registry record · NA
EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial
A NA study of Cancer Thrombosis, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01853202 is a NA study of Cancer Thrombosis that has completed, run by University of Vermont. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01853202, a NA study of Cancer Thrombosis, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with lymphoma or cancer who are receiving chemotherapy in the outpatient setting are at risk for blood clots which form in the veins. The occurrence of blood clots has major implications on personal health including the need for blood thinners and monitoring, potential bleeding, and complications related to blood clots on cardiovascular health. The goal of this study is to determine whether aerobic exercise training is a therapeutic strategy to offset risk of blood clots and improve quality of life among cancer patients during chemotherapy.
Conditions Studied
Interventions
- BEHAVIORAL Supervised aerobic exercise training
Study Locations (1)
Vermont
- Fletcher Allen Healthcare - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01853202
The ClinicalTrials.gov registry entry for NCT01853202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Supervised aerobic exercise training is the first listed.
NCT01853202 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.
Frequently Asked Questions
What is clinical trial NCT01853202 about?
NCT01853202 is a clinical study titled "EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial". Patients with lymphoma or cancer who are receiving chemotherapy in the outpatient setting are at risk for blood clots which form in the veins. The occurrence of blood clots has major implications on personal health including the need for blood thinners and monitoring, potential bleeding, and complic...
What is the current status of trial NCT01853202?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-03.
What conditions does trial NCT01853202 study?
This clinical trial studies the following conditions: Cancer Thrombosis.
What interventions are being tested in trial NCT01853202?
The interventions under investigation include: Supervised aerobic exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01853202?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01853202 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.